STOCK TITAN

Ardelyx to Participate in Upcoming Investor Conferences

(Neutral)
(Neutral)
Tags
conferences

Ardelyx (Nasdaq: ARDX) announced participation in two investor events in Miami the week of March 10, 2026: the Leerink Partners 2026 Global Healthcare Conference and the Jefferies 2026 Biotech on the Beach Summit.

The company will present at Leerink on March 10 at 4:20 p.m. ET with 1x1 meetings on March 10 and 11. A live webcast will be available on the Events and Presentations page at ir.ardelyx.com; a replay will be hosted for 30 days after the Leerink presentation.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ARDX

+6.91%
+6.91% Session close to close

In the Mar 4 session, ARDX gained 6.91%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WALTHAM, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced its participation in the following upcoming investor conferences:

Leerink Partners 2026 Global Healthcare Conference
Location: Miami, FL
Presentation: Tuesday, March 10 at 4:20 p.m. ET
1x1 Meetings: Tuesday, March 10

To access the live webcast of the Leerink presentation, please visit the Events and Presentations page within the Ardelyx website at ir.ardelyx.com. A replay of the panel presentation will be available on the Ardelyx website for 30 days following the event.

Jefferies 2026 Biotech on the Beach Summit
Location: Miami, FL
1x1 Meetings: Wednesday, March 11

About Ardelyx, Inc.
Ardelyx is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). The company’s pipeline includes the Phase 3 development of tenapanor for chronic idiopathic constipation (CIC) and RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com


FAQ

When will Ardelyx (ARDX) present at the Leerink Partners 2026 Global Healthcare Conference?

Ardelyx will present at Leerink on March 10, 2026 at 4:20 p.m. ET during the Leerink Partners Global Healthcare Conference. According to the company, the presentation is scheduled in Miami and will be webcast live via the investor Events and Presentations page.

Can investors watch the Ardelyx (ARDX) Leerink presentation via webcast?

Yes — a live webcast of the Leerink presentation will be available on March 10, 2026 via Ardelyx's investor site. According to the company, visit the Events and Presentations page at ir.ardelyx.com to access the live stream and subsequent replay.

What Ardelyx (ARDX) activities are planned at the Jefferies 2026 Biotech on the Beach Summit?

Ardelyx is scheduled for 1x1 investor meetings at Jefferies Biotech on the Beach in Miami on March 11, 2026. According to the company, these are one‑on‑one meetings and no public presentation time was provided in the announcement.

How long will the replay of Ardelyx's (ARDX) Leerink presentation be available?

A replay of the Leerink presentation will be available on Ardelyx's website for 30 days after the March 10, 2026 event. According to the company, the replay can be accessed via the Events and Presentations page at ir.ardelyx.com during that 30‑day window.